Summit Partners invests in cancer CRO LumaBridge
The funding will help LumaBridge continue to build on its work offering clinical trial solutions to support emerging biopharma companies.
23 August 2022•2 mins read
The funding will help LumaBridge continue to build on its work offering clinical trial solutions to support emerging biopharma companies.
Walter Capital Partners takes significant stake in Quebec educational games maker Passe-Temps
5 hours ago · 1 min read
Truelink Capital’s GES buys CSG Creative from National Trade Productions
5 hours ago · 2 mins read
MPE Partners’ Intermatic adds outdoor lighting-control products maker Sun-Tech
5 hours ago · 2 mins read
Velocity Capital Management backs founder Griffin Haddrill with stake in LV8, Mirage
5 hours ago · 1 min read
Aterian’s Outlook Group completes acquisition of Graham-backed ABX’s Pewaukee packaging facility
6 hours ago · 1 min read
FPE Capital’s NoBlue2 adds PeopleWalking’s Spanish NetSuite business in Europe push
6 hours ago · 1 min read
PE targets identity security as AI transforms threats: 6 deals
8 hours ago · 3 mins read
